Searched for
BASAL INSULIN THERAPY
Novo Nordisk readies once-a-week insulin shot for Indian marketNovo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment drastically cuts do...- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Biocon shares surge 3% as subsidiary obtains USFDA approval for diabetes drugBiocon share price jumped after its subsidiary Biocon Biologics received USFDA approval for Kirsty, a rapid-acting insulin biosimilar. This...
- Sanofi introduces diabetes drug Soliqua in IndiaSanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 recepto...
- Biocon Biologics' arm gets USD 90 mn contract from Malaysian government for supply of insulinsBiocon Biologics, a part of Biocon Ltd, has created a Centre of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to m...
- Biocon partners with Voluntis to develop digital therapeutics for diabetes patientsThe licensing agreement, signed between Biocon Biologics’ subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis, would make Biocon Biologics o...
- Health to become more vital politically in India: Novo Nordisk CEO Lars Rebien Sørensen"India has a high incidence of non-communicable diseases, especially diabetes, and it is mostly because it is poorly regulated," said Søren...
- Biocon gets approval for insulin Glargine in MexicoGalactus by PiSA is the first insulin Glargine to be approved in Mexico as per the biocomparable approvals pathway defined in 2012, it adde...
Load More